Singapore markets closed

NeuBase Therapeutics, Inc. (NBSE)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.4420+0.0210 (+4.99%)
At close: 04:00PM EDT
0.4300 -0.01 (-2.71%)
Pre-market: 08:32AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/09/2022
30/09/2021
30/09/2020
Cash flows from operating activities
Net income
-30,417
-33,776
-25,409
-17,385
Depreciation & amortisation
1,400
1,263
575.521
280.463
Stock-based compensation
1,595
2,898
3,696
5,195
Change in working capital
-1,976
177.067
361.159
479.303
Accounts payable
-781.566
35.142
294.548
-129.088
Other working capital
-29,829
-29,484
-20,312
-11,427
Other non-cash items
-2,173
-
2,888
-
Net cash provided by operating activities
-29,431
-29,012
-18,874
-10,710
Cash flows from investing activities
Investments in property, plant and equipment
-397.679
-471.711
-1,438
-716.82
Acquisitions, net
-
0
-1,100
0
Purchases of investments
0
-14,987
-59,989
0
Sales/maturities of investments
0
14,987
59,963
0
Net cash used for investing activities
-397.679
-471.741
-2,563
-716.82
Cash flows from financing activities
Debt repayment
-181.548
-109.5
-8.77
0
Common stock issued
-
0
42,616
33,284
Common stock repurchased
-
-
-
0
Other financing activities
-
-148.385
-381.797
-349.792
Net cash used provided by (used for) financing activities
-110.687
-257.017
42,338
33,105
Net change in cash
-29,940
-29,741
20,901
21,678
Cash at beginning of period
47,326
52,893
31,992
10,314
Cash at end of period
17,386
23,153
52,893
31,992
Free cash flow
Operating cash flow
-29,431
-29,012
-18,874
-10,710
Capital expenditure
-397.679
-471.711
-1,438
-716.82
Free cash flow
-29,829
-29,484
-20,312
-11,427